Wire Stories

Category Added in a WPeMatico Campaign

news_6

U.S. FDA Approves Supplemental New Drug Application for Takeda’s ICLUSIG® (ponatinib) for Adult Patients with Resistant or Intolerant Chronic-Phase CML

– Updated ICLUSIG Label will Prove Practice-Changing, Expanding Indication to CP-CML Patients with Resistance or Intolerance to At Least Two...

news_6

Indonesia Financial Brokerage Market Outlook to 2023 by Equity and Debt Investments Traded Value, Revenue and Frequency of Transactions – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia Financial Brokerage Market Outlook to 2023 - by Equity and Debt Investments Traded Value, Revenue and Frequency...

news_6

Global Lutein Market Size, Share, Demand & Forecast Report 2020-2027: Growing Aquaculture Industry Driving Market Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Lutein Market Size, Share, Demand By Form, By Source, By Application, By Region, Segment Forecast To 2027" report...

news_6

 CANbridge Pharmaceuticals CAN106 Investigational New Drug Application Approved in Singapore for the Treatment of Complement Dysregulation Diseases

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a company developing and commercializing innovative drugs to treat rare diseases and targeted...